Agonist trigger: what is the best approach? Agonist trigger and low dose hCG

被引：15

作者：

Humaidan, Peter ^{[1
]}

机构：

[1] Odense Univ Hosp, Fertil Clin, Dept D, DK-5000 Odense C, Denmark

来源：

FERTILITY AND STERILITY | 2012年 / 97卷 / 03期

关键词：

GnRHa; GnRH antagonist; OHSS; hCG; ovulation induction; OVARIAN HYPERSTIMULATION SYNDROME; FINAL OOCYTE MATURATION; GNRH AGONIST; CORPUS-LUTEUM; COMBINATION; INDUCTION; RESCUE; OVULATION; CYCLES; IVF;

D O I：

10.1016/j.fertnstert.2011.11.016

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Low-dose hCG supplementation after GnRH agonist trigger may normalize reproductive outcome while minimizing the occurrence of OHSS in high risk IVF patients. (Fertil Steril (R) 2012;97:529-30. (C) 2012 by American Society for Reproductive Medicine.)

引用

页码：529 / 530

页数：2

共 23 条

[11]

ITSKOVITZ J, 1991, FERTIL STERIL, V56, P213

[12] A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists [J].

Kolibianakis, EM ;

Schultze-Mosgau, A ;

Schroer, A ;

van Steirteghem, A ;

Devroey, P ;

Diedrich, K ;

Griesinger, G .

HUMAN REPRODUCTION, 2005, 20 (10) :2887-2892

[13] On the role of human chorionic gonadotropin (hCC) in the embryo-endometrial microenvironment: Implications for differentiation and implantation [J].

Licht, P ;

Russu, V ;

Wildt, L .

SEMINARS IN REPRODUCTIVE MEDICINE, 2001, 19 (01) :37-47

[14] Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles [J].

Papanikolaou, EG ;

Pozzobon, C ;

Kolibianakis, EM ;

Camus, M ;

Tournaye, H ;

Fatemi, HM ;

Van Steirteghem, A ;

Devroey, P .

FERTILITY AND STERILITY, 2006, 85 (01) :112-120

[15] Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates [J].

Radesic, B. ;

Tremellen, K. .

HUMAN REPRODUCTION, 2011, 26 (12) :3437-3442

[16] Multiple novel roles of luteinizing hormone [J].

Rao, CV .

FERTILITY AND STERILITY, 2001, 76 (06) :1097-1100

[17]

ROSENBERG SM, 1980, FERTIL STERIL, V34, P17

[18] Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin [J].

Shapiro, Bruce S. ;

Daneshmand, Said T. ;

Garner, Forest C. ;

Aguirre, Martha ;

Hudson, Cynthia .

FERTILITY AND STERILITY, 2011, 95 (08) :2715-2717

[19] Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy [J].

Sugino, N ;

Kashida, S ;

Takiguchi, S ;

Karube, A ;

Kato, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3919-3924

[20] Comparison of LH concentrations in the early and midluteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix [J].

Tavaniotou, A ;

Albano, C ;

Smitz, J ;

Devroey, P .

HUMAN REPRODUCTION, 2001, 16 (04) :663-667

← 1 2 3 →